<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Till Cap Ltd</title><link>https://investorshangout.com/Till-Cap-Ltd-TILCF-91019/</link><description><![CDATA[Till Cap Ltd (TILCF)]]></description><language>en-us</language><pubDate>Tue, 08 Sep 2026 19:52:09 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Till-Cap-Ltd-TILCF-91019/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $TIL News Article - Expected earnings - Instil Bio Inc. </title><link>https://investorshangout.com/post/view?id=6643476</link><guid>https://investorshangout.com/post/view?id=6643476</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 13 Nov 2023 18:00:51 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - EXCLUSIVE: Better For You Wellness To Acquire Ideation Lab, Jordre Well And Its </title><link>https://investorshangout.com/post/view?id=6620289</link><guid>https://investorshangout.com/post/view?id=6620289</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 19 Sep 2023 17:45:46 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British S</title><link>https://investorshangout.com/post/view?id=6589923</link><guid>https://investorshangout.com/post/view?id=6589923</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 26 Jun 2023 20:45:48 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-3</title><link>https://investorshangout.com/post/view?id=6520477</link><guid>https://investorshangout.com/post/view?id=6520477</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 09 Jan 2023 19:34:50 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Instil Bio, In</title><link>https://investorshangout.com/post/view?id=6493051</link><guid>https://investorshangout.com/post/view?id=6493051</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 02 Nov 2022 16:50:52 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - Instil Bio Reports Second Quarter 2022 Financial Results and Provides Corporate </title><link>https://investorshangout.com/post/view?id=6453550</link><guid>https://investorshangout.com/post/view?id=6453550</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 12 Aug 2022 18:30:52 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - Instil Bio Reports First Quarter 2022 Financial Results and Provides Corporate U</title><link>https://investorshangout.com/post/view?id=6404093</link><guid>https://investorshangout.com/post/view?id=6404093</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 16 May 2022 18:00:51 GMT</pubDate></item><item><title>whytestocks: $TIL News Article - At a Recent Cancer Research Conference, Instil Bio Stole the Show </title><link>https://investorshangout.com/post/view?id=6121922</link><guid>https://investorshangout.com/post/view?id=6121922</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 29 Apr 2021 19:50:51 GMT</pubDate></item></channel></rss>